top of page
Search

Patients Are Increasingly Using Digital Health to Supplement Doctor Visits
61% of patients reported that they were likely to ask for a specific prescription medication by name, implying research prior to...
by Jasmine Pennic / hitconsultant.net
2 min read


The Safety of Biosimilars and the importance of the INN to track and trace the use of a medicine gi
Tracking and tracing the use of all biologics, including biosimilars, enhances patient safety. Where there are multiple companies...
© 2015 Amgen Inc. All Rights Reserved.
2 min read


Name that drug
The role of the European Medicines Agency (EMA) as a regulator is to protect and promote public and animal health by evaluating and...
Edward Carstairs of Gill Jennings & Every LLP
4 min read


What's the Prescription for a Perfect Name?
With Viagra and Prozac rivaling McDonald's and Coca-Cola among today's most frequently used brand names, it's no surprise that...
By Paul Norman / Pharmaceutical Executive Europe
7 min read

EGA Becomes Medicines for Europe
The European Generic and Biosimilar Medicines Association (EGA) has changed its name to Medicines for Europe. In a press release issued...
By Pharmaceutical Executive Editors
3 min read


Hanmi's $200M China plant likely to make branded drugs versus generics
South Korean drug manufacturer Hanmi is building a $200 million manufacturing plant and R&D center in China, though it won't, apparently,...
by Joseph Keenan / FiercePharma
2 min read


Top three therapy areas dominate pipelines
The world's top three therapy areas accounted for 68 percent of the overall pharmaceutical industry pipeline as of Q1 2016, according to...
George Underwood / PharmaTimes
2 min read


GSK teams up with Google on bioelectronic medicines
GlaxoSmithKline is teaming up with Google's parent company Alphabet to create a new company focused on developing bioelectronic...
by Selina McKee / PharmaTimes online
2 min read


Value-based care necessitates big changes for pharma marketers, says digital pharma agency
Much has been discussed, and some dismissed, when it comes to value-based care in the pharma industry. However, no one can deny that the...
by Beth Snyder Bulik / FiercePharma
2 min read

India’s Drug Approvals Near Record Despite FDA Inspection Blitz
Even as the FDA has increased scrutiny of India, it’s been approving generic drug applications from the country’s firms at a record pace....
by Ari Altstedter and Manish Modi / Bloomberg
3 min read
bottom of page